Arrowhead Pharmaceuticals Inc (ARWR)

Deferred Revenue

$94.60M

Quarterly · Period ending: · USD

ARWR logo

ARWR Deferred Revenue

Latest reported$94.60M
ARWR Quarterly Deferred Revenue ($0.00 → $94.60M)
High-resolution chart · PNG

ARWR deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrowhead Pharmaceuticals Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
94,596,000
108,543,000
111,933,000
2,399,000
22,979,000
43,268,000
0
0
0
0
0
866,000
16,905,000
29,839,000
66,281,000
74,099,000
84,288,000
97,869,000
108,652,000
111,055,000
150,934,000
144,879,000
6,744,000
19,291,075
26,274,362
33,174,765
54,034,129
77,769,629
75,681,868
90,889,801
124,925,638
600
943,200
1,565,000
1,875,000
5,269,741
13,283,006
21,169,191
25,584,181
3,010,372
26,042
65,625
109,375
103,125
71,875
65,625
109,375
103,125
71,875
65,625
109,375
103,125
71,875
65,625
109,375
37,500
71,875
69,792
101,042
0
0
0
3,034,855
686,161
914,935
0
0
420,077
867,290
1,292,652
1,636,861
1,094,549
0
0
37,999
98,570
378,645
0
0
0
0
31,250
68,750
106,250
143,750
0
0
0
0
0
0
0
0
0
0
0
0
0
0
611,751
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.